lithium has been researched along with Akinetic-Rigid Variant of Huntington Disease in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 28 (80.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (8.57) | 29.6817 |
| 2010's | 4 (11.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, F; Qin, ZH | 1 |
| Chiu, CT; Chuang, DM; Leeds, P; Liu, G | 1 |
| Albin, RL; Tallaksen-Greene, SJ | 1 |
| Brillaud, E; Cattaneo, E; Compte, E; Conforti, P; Ehrnhoefer, DE; Franciosi, S; Graham, RK; Hayden, MR; Maurel, JC; Néri, C; Poucheret, P; Pouladi, MA; Xie, Y; Zhang, W; Zuccato, C | 1 |
| Chuang, DM; Kanai, H; Ren, M; Senatorov, VV; Wei, H | 1 |
| Chuang, DM | 1 |
| Ananth, J; Yassa, R | 1 |
| Yung, CY | 1 |
| Zaleska, B | 1 |
| Chuang, DM; Qian, Y; Qin, ZH; Senatorov, VV; Wang, Y; Wei, H; Wei, W | 1 |
| Carolei, A; Del Castillo, G | 1 |
| Bailey, E; Bond, PA; Brooks, BA; Dimitrakoudi, M; Jenner, FA; Judd, A; Lee, CR; Lenton, EA; McNeil, S; Pollitt, RJ; Sampson, GA; Thompson, EA | 1 |
| Brown, JG; Kidson, MA; Leonard, DP; Shannon, PJ; Taryan, S | 1 |
| Nyberg-Hansen, R | 1 |
| Merskey, H | 1 |
| Kuran, W | 1 |
| Foerster, K; Regli, F | 1 |
| Baastrup, PC; Petersson, H; Vestergaard, P | 1 |
| Vestergaard, P; Yates, CM | 1 |
| Alelov, M; Flechter, S; Rabey, Y; Streifler, M; Vardi, J | 1 |
| Chiu, E; Mann, J | 1 |
| Dalén, P | 2 |
| Mattsson, B | 1 |
| Carman, JS | 1 |
| Bravo-Fernandez, E; Manyam, NV | 1 |
| Andén, NE; Dalén, P; Johansson, B | 1 |
| Manyam, NV | 1 |
| Mattsson, B; Persson, SA | 1 |
| Aminoff, MJ; Marshall, J | 1 |
| Leijnse-Ybema, HJ; Schenk, G | 1 |
| Carman, JS; Chase, TN; Shoulson, I | 1 |
| Worrall, EP | 1 |
| Brown, J; Kidson, MA; Leonard, DP; Shannon, PJ | 1 |
| Aminoff, MJ; Marshall, J; Smith, E; Wyke, M | 1 |
7 review(s) available for lithium and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Degradation of misfolded proteins by autophagy: is it a strategy for Huntington's disease treatment?
Topics: Autophagy; Carbamazepine; Humans; Huntingtin Protein; Huntington Disease; Lithium; Mutant Proteins; Nerve Tissue Proteins; Oxazoles; Peptides; Rilmenidine; Sirolimus; Trehalose; Trinucleotide Repeat Expansion; Valproic Acid | 2013 |
Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases?
Topics: Animals; Cells, Cultured; Humans; Huntington Disease; Lithium; Mice; Neurodegenerative Diseases; Neuroprotective Agents; Nootropic Agents; Rats; Stroke | 2004 |
Lithium carbonate in the treatment of movement disorders. A critical review.
Topics: Adult; Aged; Antipsychotic Agents; Clinical Trials as Topic; Deanol; Dopamine; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Huntington Disease; Lithium; Lithium Carbonate; Male; Middle Aged; Tourette Syndrome | 1980 |
A review of clinical trials of lithium in neurology.
Topics: Clinical Trials as Topic; Cluster Headache; Dyskinesia, Drug-Induced; Epilepsy; Headache; Humans; Huntington Disease; Hyperkinesis; Levodopa; Lithium; Meniere Disease; Migraine Disorders; Movement Disorders; Nervous System Diseases; Neurocognitive Disorders; Parkinson Disease; Sleep Wake Disorders; Torticollis | 1984 |
[Progress in the treatment of degenerative diseases of the nervous system. Selected problems].
Topics: Amyotrophic Lateral Sclerosis; Antiparkinson Agents; Humans; Huntington Disease; Lithium; Neostigmine; Parkinson Disease; Penicillamine; Phthalazines; Selegiline; Tetrabenazine; Tiapamil Hydrochloride | 1980 |
[Recent neurobiological and related pharmaco-therapeutic acquisitions in Huntington's chorea].
Topics: Amphetamine; Antipsychotic Agents; Brain; Butyrophenones; gamma-Aminobutyric Acid; Humans; Huntington Disease; Kainic Acid; Levodopa; Lithium; Neurotransmitter Agents; Phenothiazines; Sympatholytics; Tetrabenazine | 1979 |
Neurology and psychopharmacology.
Topics: Analgesia; Depression; Humans; Huntington Disease; Hysteria; Lithium; Movement Disorders; Parkinson Disease; Parkinson Disease, Secondary; Phenothiazines; Psychopharmacology; Psychotic Disorders; Psychotropic Drugs; Schizophrenia; Thioxanthenes | 1975 |
12 trial(s) available for lithium and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Lithium carbonate in the treatment of movement disorders. A critical review.
Topics: Adult; Aged; Antipsychotic Agents; Clinical Trials as Topic; Deanol; Dopamine; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Huntington Disease; Lithium; Lithium Carbonate; Male; Middle Aged; Tourette Syndrome | 1980 |
A review of clinical trials of lithium in neurology.
Topics: Clinical Trials as Topic; Cluster Headache; Dyskinesia, Drug-Induced; Epilepsy; Headache; Humans; Huntington Disease; Hyperkinesis; Levodopa; Lithium; Meniere Disease; Migraine Disorders; Movement Disorders; Nervous System Diseases; Neurocognitive Disorders; Parkinson Disease; Sleep Wake Disorders; Torticollis | 1984 |
A double blind trial of lithium carbonate and haloperidol in Huntington's chorea.
Topics: Anger; Carbonates; Clinical Trials as Topic; Depression; Depression, Chemical; Drug Therapy, Combination; Female; Haloperidol; Humans; Huntington Disease; Lithium; Placebos | 1975 |
Lithium treatment of Huntington's chorea. A placebo-controlled clinical trial.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Humans; Huntington Disease; Lithium; Male; Middle Aged; Placebos; Time Factors | 1977 |
Lithium carbonate in Huntington's chorea.
Topics: Activities of Daily Living; Adult; Clinical Trials as Topic; Haloperidol; Humans; Huntington Disease; Lithium; Male | 1973 |
Huntington's chorea, lithium, and G.A.B.A.
Topics: Aminobutyrates; Clinical Trials as Topic; Humans; Huntington Disease; Lithium; Placebos; Serotonin | 1973 |
Treatment of Huntington's chorea with lithium carbonate. A double-blind trial.
Topics: Adult; Carbonates; Clinical Trials as Topic; Corpus Striatum; Drug Evaluation; Female; Humans; Huntington Disease; Lithium; Male; Middle Aged; Motor Skills; Placebos; Psychological Tests; Serotonin; Task Performance and Analysis | 1974 |
Letter: Lithium and Huntington's chorea.
Topics: Clinical Trials as Topic; Drug Antagonism; Drug Therapy, Combination; Humans; Huntington Disease; Lithium; Phenothiazines; Tetrabenazine | 1974 |
Letter: Huntington's chorea treated with lithium carbonate.
Topics: Carbonates; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Huntington Disease; Hypocalcemia; Lithium; Male; Placebos; Tranquilizing Agents | 1974 |
Letter: Lithium in Huntington's chorea.
Topics: Aggression; Clinical Trials as Topic; Humans; Huntington Disease; Lithium | 1974 |
Letter: Double-blind trial of lithium carbonate and haloperidol in Huntington's chorea.
Topics: Behavior; Carbonates; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Haloperidol; Humans; Huntington Disease; Lithium; Personality Disorders; Placebos | 1974 |
Letter: Cognitive function in patients on lithium therapy.
Topics: Cognition; Dementia; Humans; Huntington Disease; Intelligence Tests; Lithium; Placebos | 1974 |
18 other study(ies) available for lithium and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease.
Topics: Affect; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Huntington Disease; Lithium; Male; Mice; Mice, Transgenic; Valproic Acid | 2011 |
Treating mouse models of Huntington disease.
Topics: Affect; Animals; Female; Huntington Disease; Lithium; Male; Valproic Acid | 2011 |
NP03, a novel low-dose lithium formulation, is neuroprotective in the YAC128 mouse model of Huntington disease.
Topics: Animals; Brain; Disease Models, Animal; Female; Humans; Huntington Disease; Immunoblotting; Lithium; Male; Mice; Motor Activity; Neuroprotective Agents; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction | 2012 |
Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease.
Topics: Animals; Apoptosis; Cell Division; Cell Survival; Corpus Striatum; DNA Damage; Dose-Response Relationship, Drug; Huntington Disease; Interneurons; Lithium; Male; Neurons; Neuroprotective Agents; Neurotoxins; Proto-Oncogene Proteins c-bcl-2; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Up-Regulation | 2004 |
Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington's disease.
Topics: Animals; Antimanic Agents; Benzazepines; Cell Death; Cyclin D1; Disease Models, Animal; Dopamine Antagonists; Glutamate Decarboxylase; Huntington Disease; Immunohistochemistry; In Situ Nick-End Labeling; Isoenzymes; Lithium; Lithium Chloride; Male; Neostriatum; Neurons; Neuroprotective Agents; Neurotoxins; Quinolinic Acid; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; RNA, Messenger | 2001 |
The medicinal chemistry of lithium.
Topics: Adenylyl Cyclases; Adrenal Cortex; Affective Symptoms; Animals; Antidepressive Agents; Bipolar Disorder; Chlorpromazine; Depression; Drug Evaluation; Drug Tolerance; Epilepsy; Female; Humans; Huntington Disease; Kidney; Lithium; Menstruation Disturbances; Neurotic Disorders; Psychotherapy; Psychotic Disorders; Schizophrenia; Thyroid Gland; Water | 1975 |
[Editorial: Treatment of choriatic movements].
Topics: Chorea; Humans; Huntington Disease; Lithium; Tetrabenazine; Tranquilizing Agents | 1975 |
[Modern methods of treating Huntington's chorea].
Topics: gamma-Aminobutyric Acid; Haloperidol; Humans; Huntington Disease; Lithium; Methysergide; Physostigmine; Tetrabenazine | 1976 |
[Lithium therapy of extrapyramidal movement disorders-an attempt (author's transl)].
Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Female; Humans; Huntington Disease; Lithium; Male; Middle Aged; Torticollis | 1977 |
Amine metabolites in cerebrospinal fluid from Huntigton's chorea patients treated with lithium.
Topics: Adult; Biogenic Amines; Double-Blind Method; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Lithium; Male; Methoxyhydroxyphenylglycol; Middle Aged | 1978 |
[Lithium carbonate in Huntington's disease].
Topics: Carbonates; Humans; Huntington Disease; Lithium | 1978 |
Platelet monoamine oxidase activity in Huntington's chorea.
Topics: Adult; Aged; Blood Platelets; Female; Haloperidol; Humans; Huntington Disease; Lithium; Male; Middle Aged; Monoamine Oxidase; Pimozide; Sex Factors; Tetrabenazine | 1978 |
Lithium therapy in Huntington's chorea and tardive dyskinesia.
Topics: Adult; Aged; Female; Humans; Huntington Disease; Lithium; Middle Aged; Movement Disorders | 1973 |
Huntington's chorea and lithium therapy.
Topics: Adult; Carbonates; Female; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Lithium; Male; Middle Aged; Phenylacetates | 1973 |
Lithium in chorea.
Topics: Dopamine; Humans; Huntington Disease; Lithium | 1973 |
Baclofen and lithium in Huntington's chorea.
Topics: Adult; Aged; Aminobutyrates; Benzene Derivatives; Drug Interactions; Female; Humans; Huntington Disease; Lithium; Middle Aged; Parasympatholytics | 1973 |
Serotonin, lithium, and Huntington's chorea.
Topics: Animals; Brain; Dopamine; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Lithium; Serotonin | 1973 |
Letter: Huntington's chorea and levodopa.
Topics: Carboxy-Lyases; Dihydroxyphenylalanine; Drug Interactions; Drug Therapy, Combination; Haloperidol; Homovanillic Acid; Humans; Huntington Disease; Lithium; Male; Phenylacetates | 1974 |